AH-7921

AH-7921
Clinical data
Other namesAH-7921
Routes of
administration		Recreational: insufflation, sublingual, intravenous, oral, rectal
ATC code
  • none
Legal status
Legal status

In General Unscheduled, Illegal in Sweden, Czech Republic, China, Brazil and Israel.

Identifiers
  • 3,4-dichloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC16H22Cl2N2O
Molar mass329.27 g·mol−1
3D model (JSmol)
  • ClC1=CC=C(C(NCC2(CCCCC2)N(C)C)=O)C=C1Cl
  • InChI=1S/C16H22Cl2N2O/c1-20(2)16(8-4-3-5-9-16)11-19-15(21)12-6-7-13(17)14(18)10-12/h6-7,10H,3-5,8-9,11H2,1-2H3,(H,19,21) Y
  • Key:JMZROFPPEXCTST-UHFFFAOYSA-N Y
 NY (what is this?)  (verify)

AH-7921 (Doxylam) is an opioid analgesic drug selective for the μ-opioid receptor, having around 90% the potency of morphine when administered orally. It was discovered in the 1970s by a team at Allen and Hanburys located in the United Kingdom. The drug is considered a new psychoactive substance (NPS) in which it is synthetically created in laboratories to mimic that of controlled substances. The substance has also been sold on the internet since 2012 as a "research chemical". When sold online it may be called the alternative name doxylam, not to be confused with doxylamine. AH-7921 has never progressed to clinical trials. The DEA is not aware of any medical usage in the United States, and has not insisted the Health and Human Services department (HHS) to conduct any medical research of the substance's uses.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.